Luckett, PH;
McCullough, A;
Gordon, BA;
Strain, J;
Flores, S;
Dincer, A;
McCarthy, J;
... Dominantly Inherited Alzheimer Network (DIAN), .; + view all
(2021)
Modeling autosomal dominant Alzheimer's disease with machine learning.
Alzheimer's & Dementia
, 17
(6)
pp. 1005-1016.
10.1002/alz.12259.
Preview |
Text
Modeling autosomal dominant AlzDem - final accepted ms.pdf - Accepted Version Download (1MB) | Preview |
Abstract
INTRODUCTION: Machine learning models were used to discover novel disease trajectories for autosomal dominant Alzheimer's disease. METHODS: Longitudinal structural magnetic resonance imaging, amyloid positron emission tomography (PET), and fluorodeoxyglucose PET were acquired in 131 mutation carriers and 74 non-carriers from the Dominantly Inherited Alzheimer Network; the groups were matched for age, education, sex, and apolipoprotein ε4 (APOE ε4). A deep neural network was trained to predict disease progression for each modality. Relief algorithms identified the strongest predictors of mutation status. RESULTS: The Relief algorithm identified the caudate, cingulate, and precuneus as the strongest predictors among all modalities. The model yielded accurate results for predicting future Pittsburgh compound B (R2 = 0.95), fluorodeoxyglucose (R2 = 0.93), and atrophy (R2 = 0.95) in mutation carriers compared to non-carriers. DISCUSSION: Results suggest a sigmoidal trajectory for amyloid, a biphasic response for metabolism, and a gradual decrease in volume, with disease progression primarily in subcortical, middle frontal, and posterior parietal regions.
Type: | Article |
---|---|
Title: | Modeling autosomal dominant Alzheimer's disease with machine learning |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1002/alz.12259 |
Publisher version: | https://doi.org/10.1002/alz.12259 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
Keywords: | Pittsburgh compound B (PiB), autosomal dominant Alzheimer's disease (ADAD), fluorodeoxyglucose (FDG), machine learning, magnetic resonance imaging (MRI) |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10120804 |
Archive Staff Only
View Item |